Tuesday, April 5, 2022
Investment Bank Outlook 05-04-2022
from Tickmill Expert Blog - Forex Traders Blog https://www.tickmill.com/blog/investment-bank-outlook-05-04-2022"
via IFTTT
Corn Futures (ZC1!), H1 Potential for Bullish Rise!
from Tickmill Expert Blog - Forex Traders Blog https://www.tickmill.com/blog/corn-futures-zc1-h1-potential-for-bullish-rise"
via IFTTT
Three healthcare trusts to invest in
The remarkable speed at which scientists were able to discover new vaccines and treatments during the pandemic and roll out mass usage seemed to show that there is no medical affliction which is beyond the scope of ingenuity and innovation. This seemed likely to usher in a new golden era for the healthcare sector, and for biotechnology in particular, that would boost the private companies at the forefront of the medical revolution.
Instead the biotech sector is in its biggest bear market in 30 years. In 12 months, the S&P Biotechnology index has lagged the S&P 500 by 64%, falling nearly 50% back to the level of mid 2015. The broader healthcare sector has fared better, thanks to the resilient share prices of big pharmaceutical firms and healthcare service providers. But smaller, innovative companies focusing on research and development rather than shortterm cash flow have suffered.
Time for the tide to turn
In the year to 28 February, the net asset value of Worldwide Healthcare Trust (LSE: WWH) was down 9%, and that of its sister trust Biotech Growth Trust (LSE: BIOG) was down 35%, each 22% behind their benchmark indices. “Fundamentals did not matter,” says Sven Borho, co-manager of WWH. “Everything was driven by macro trends such as growth into value”. In addition to the poor performance of biotech (22% of WWH’s portfolio, 82% of BIOG’s), exposure to the massive under-performance of Chinese companies (8% in both), also hurt the trusts, he notes.
Still, “the healthcare sector now trades on a 20% discount to the S&P 500, the same as in the financial crisis”, says Borho. “Every single time it has traded at such a discount has been the very best time to be invested, especially in innovation and growth.” Meanwhile, the threat of drug pricing reform and regulatory change in the US has lifted. “We are very confident of recapturing much of the lost performance of WWH and BIOG… We have bounced back from setbacks before.”
Controlling the costs
By far the best performer in the sector is the £1bn BB Healthcare trust (LSE: BBH), which is up by 84%, over the past five years. Manager Paul Major has focused on the rising cost of healthcare – which accounted for 10% of US GDP in 1980 but is now 18% – as a key theme. “The compound annual real growth rate of NHS expenditure is 2.25% but needs to be 3.5%.
Thanks to ageing populations, scientific progress and increasing wealth, healthcare is the secular growth story of our age but it needs to be paid for.” BBH invests in firms that “provide innovative solutions for broken healthcare systems around the world”. For example, healthcare waste in the US is estimated at $750bn per annum.
“The political discussion in the US is about prescription drugs but they only account for 10% of total spending. Hospital care accounts for 31% and physicians and clinics 20%.” This is where efficiency can improve, says Major. “Hospitals are expensive and nobody wants to be there, so newer care models are needed. The first interaction of patients with healthcare needs to be online.”
Other areas of focus are diagnostics, patient monitoring, disease prevention and changing behaviour. “People do not follow medical advice or behave rationally so they need to be nudged. For example, 15% of those with cancer in the US are not receiving treatment. Sensory technology can be used for monitoring the treatment of patients so that their arrival in hospital represents a last resort.”
Other areas of focus are diagnostics, patient monitoring, disease prevention and changing behaviour. “People do not follow medical advice or behave rationally so they need to be nudged. For example, 15% of those with cancer in the US are not receiving treatment. Sensory technology can be used for monitoring the treatment of patients so that their arrival in hospital represents a last resort.”
from Moneyweek RSS Feed https://moneyweek.com/investments/funds/604657/three-healthcare-trusts-to-invest-in
via IFTTT
Buy Bank of Georgia: a cheap play on a robust economy
Investing in any bank’s shares may seem a contrarian proposition at the moment. Investing in a bank in a country that has been invaded by Russia might then seem on the hazardous side of contrarian.
Yet the Russian invasion of Georgia happened in 2008 and that means further military conflict is unlikely. Therein lies the opportunity.
Vladimir Putin’s invasion in 2008 in support of South Ossetia (a Russia-friendly breakaway province) was a brief and one-sided escapade. Sadly it may even have encouraged the Russian tyrant to think that an invasion of Ukraine would be similar.
A solid economy
Following the invasion, Georgia is now less reliant on Russia both as an export market (14% of exports) and as a source of remittance flows from Georgians working abroad who send money back home (now 12%, down from half ten years ago). The rich volcanic Georgian soil means that the country is less exposed to rising wheat prices or a shortage in fertiliser than many. Georgia is also less vulnerable to higher energy costs than in the past, after a decade of investment in hydro power dams.
These made up 70% of energy production last year. In short, the difficult recent history since the fall of the Soviet Union has been a catalyst for the country to become more resilient.
The economy has been strong, with real GDP growth of 5% per year for the three years preceding the pandemic. Growth is forecast to be 3% in 2022, assuming the conflict in Ukraine is resolved in a few months’ time, according to Galt & Taggart (G&T), Bank of Georgia’s brokerage business (named after the characters in Ayn Rand’s Atlas Shrugged).
Even in the worst-case scenario of a prolonged conflict in Ukraine and sanctions applied to Russia’s oil and gas exports, G&T predict a 1% contraction in the economy.
This may be too pessimistic, since Georgia is a relatively stable destination in the region. I’ve heard stories of flights to Tbilisi from Moscow and St. Petersburg being booked out as skilled Russians flee Putin’s regime.
Managing the risks well
London-listed Bank of Georgia (LSE: BGEO) is one of two leading local banks. It’s cheap and in fine shape (see below), although obviously not risk-free. Around 60% of the bank’s balance sheet (both loans and deposits) is in US dollars or other foreign currencies. This would be an issue if the currency devalues steeply: borrowers who earn in local currency could struggle to service their dollar debts.
Some of this risk is reduced by the 1.3 million Georgians who earn overseas in foreign currencies and send money home. In 2021, remittances were up by 25% year-on-year, and by 36%from 2019.
The central bank, which has been increasing its $4bn in foreign-currency reserves, is aware of the devaluation risk and requires banks to have higher capital weightings for foreign-currency loans. It has also set the maximum term of a foreign-currency mortgage to ten years, as a further incentive to encourage borrowing in lari, the local currency. Thus lower interest costs on foreign-currency mortgages are offset by higher principal repayments.
Sulkhan Gvalia, finance director of the Bank of Georgia, who used to be head of risk management, has just bought £200,000-worth of shares at around £12. I met him when I listed the bank on the London Stock Exchange a decade ago, and he struck me as a shrewd character with a common-sense approach to risk management that larger, supposedly more sophisticated, banks in the US and Europe could have benefited from.
While the share price fell steeply during the financial crisis and Russian invasion, the bank didn’t need a large rescue rights issue or rely on a government bailout. I own the shares and think that there is plenty of upside to compensate for the perceived risks.
from Moneyweek RSS Feed https://moneyweek.com/investments/stocks-and-shares/bank-stocks/604646/buy-bank-of-georgia
via IFTTT
AU200AUD, H4 Potential For Upside
from Tickmill Expert Blog - Forex Traders Blog https://www.tickmill.com/blog/au200aud-h4-potential-for-upside"
via IFTTT
AUDCHF, H4 | Potential Bullish Rise
from Tickmill Expert Blog - Forex Traders Blog https://www.tickmill.com/blog/audchf-h4-or-potential-bullish-rise5"
via IFTTT
Monday, April 4, 2022
Gold Futures (GC!), H1 Potential for Bounce!
from Tickmill Expert Blog - Forex Traders Blog https://www.tickmill.com/blog/gold-futures-gc-h1-potential-for-bounce4"
via IFTTT
Wheat Futures (ZW1!), H1 Bullish Bounce
from Tickmill Expert Blog - Forex Traders Blog https://www.tickmill.com/blog/wheat-futures-zw1-h1-bullish-bounce"
via IFTTT
Nasdaq Futures (NQ1!), H1 Potential for Bearish Dip!
from Tickmill Expert Blog - Forex Traders Blog https://www.tickmill.com/blog/nasdaq-futures-nq1-h1-potential-for-bearish-dip"
via IFTTT
Soybeans Future (ZS1!), H1 Bullish Rise
from Tickmill Expert Blog - Forex Traders Blog https://www.tickmill.com/blog/soybeans-future-zs1-h1-bullish-rise"
via IFTTT
Dax Futures (FDAX1!), H1 Potential For A Rise!
from Tickmill Expert Blog - Forex Traders Blog https://www.tickmill.com/blog/dax-futures-fdax1-h1-potential-for-a-rise"
via IFTTT
Corn Futures (ZC1!), H1 Potential for Bearish Dip!
from Tickmill Expert Blog - Forex Traders Blog https://www.tickmill.com/blog/corn-futures-zc1-h1-potential-for-bearish-dip4"
via IFTTT
The FTSE 100 is doing moderately well – can this continue?
The first quarter of 2022 is over.
It's a natural point at which to take stock of what's happened in markets.
It's also a completely arbitrary point, of course. Just because markets have been doing something over the past three months doesn't mean they'll keep doing it.
Yet, arbitrary or not, taking a snapshot of markets can give us an idea of what the overall narrative is at any given time.
And it's very clear from the first quarter of this year that the big stories in investment are now dramatically different to the ones that drove the post-2009 bull market...
The FTSE 100 is doing well – what's gone wrong with the world?
One of the most obvious changes in the investment environment is that the UK's headline stock market index isn't clutching tightly to the wooden spoon for once. That's quite the shift.
During the first quarter of 2022, the FTSE 100, which comprises the 100(-ish) biggest (in terms of market capitalisation) companies listed on the London Stock Exchange, gained 1.8%, notes George Steer in the FT.
You may not be cracking open the champagne on that sort of gain (certainly not with inflation sitting at its present levels). And if you'd been more adventurous, investing in Brazil say, you'd be up a whopping 34.3%, says Morningstar.
But it's rather a lot better than if you'd invested in most other major developed global stock markets – or British ones for that matter.
The FTSE 250, which comprises the next 250(-ish) companies, lost 10.6%, while the biggest companies on Aim – London's junior market - lost an even more brutal 16%.
As for international comparisons, eurozone stocks (as measured via the Stoxx 600 index) fell by 6.5%, while the S&P 500 dropped 4.9%.
There's a pretty straightforward story to tell here. The FTSE 100 has done reasonably well for two main reasons. One is that it has been the least popular developed market in the world for a long time now, so it was starting from a low base. That shunning was partly due to Brexit.
Two - which has nothing to do with Brexit – is that it is full of the sorts of stocks that everyone has hated for the duration of the post-2008 bull market. The FTSE 100 has banks (at the heart of the last bubble); miners and oil companies (hated because they're the opposite of both ESG and "digital" assets); and a distinct lack of hot tech stocks.
Oh and it's a dividend-heavy index in a world that had decided that regular payouts to investors showed that a company had run out of imagination.
So in a world where investors have decided that "value" investing is a dirty word, it's little surprise that the FTSE 100 index was hated.
Clearly that's changing now. Even before Russia invaded Ukraine, commodity and energy prices were surging. Inflation finally stopped being described as "transitory" in December last year as the Federal Reserve "retired" the word.
Meanwhile, on the other side of the equation, anything speculative (in other words, any asset where profits are a distant prospect) has struggled. "Growth" has lost its popularity. "Virtual" has become less appealing. "Expensive" is no longer a synonym for "high-quality".
This helps to explain why the US in particular – previously the world's leading stock market by far – has started to struggle. It's far more "growth-y" and "tech-y" than the FTSE 100.
The trend is clear. The rationale is pretty clear too. The big question now is: is it likely to continue?
How to invest for a continuing shift to value from growth
On the "big picture" level, a lot of this boils down to what you think will happen to interest rates, inflation and the economy over the coming year.
If you think that inflation will drop back down and that the world's central banks are going to be clear to cut interest rates, but that we'll scrape by avoiding a recession, then we could probably flip back to the good old days of growth trumping everything and everything being hunky-dory in a slightly glum manner.
If you think that inflation will persist, that central banks are caught between a rock and a very hard place, and that we might end up with the economy being dragged down by soaring living costs even as staff agitate for higher pay to compensate and countries scramble to secure scarce supplies of key resources – well, we can probably expect more of the same.
I'll admit I find scenario number two or some variation thereof the most likely option here. I would prefer a more cheerful outcome (and if wages start rising in a persistent manner, that would make me more optimistic about the economy, if not about earnings prospects).
But overall, it's hard to see how we go back to the previous "secular stagnation" scenario which sounded very gloomy but in practice, entrenched the dominance of the top performers and wasn't much of a problem as far as Wall Street was concerned.
How do you play this? We've looked at lots of ways to play lots of different commodities, from copper to silver and platinum. You could also invest in value-oriented investment trusts or those which are aimed at protecting you from inflation.
The other option is to look at a simple FTSE 100 tracker fund. It won't give you pure exposure to all of the things that will do best out of any shift from growth to value, but it is a cheap option for investing in the overall shift.
On that note, for more on the debate over passive investing and its impact on markets, you really should listen to this week's MoneyWeek podcast, in which Merryn chats to Robin Wigglesworth, FT journalist and author of Trillions, an in-depth history of index investing and its impacts. Have a listen here.
from Moneyweek RSS Feed https://moneyweek.com/investments/stockmarkets/uk-stockmarkets/604664/fsfs
via IFTTT
GBPAUD H4, Potential For Bounce!
from Tickmill Expert Blog - Forex Traders Blog https://www.tickmill.com/blog/gbpaud-h4-potential-for-bounce"
via IFTTT
Don’t count resources out
Commodities have performed poorly over the past year, but they tend to move in long and volatile cycles. from Moneyweek RSS Feed https://m...
-
The new strain of covid found in South Africa could disrupt plans by governments and central banks to rebuild economies. Financial markets a...
-
Fidelity “FIS” is a global financial services technology company and a leader in providing technology solutions to merchants, banks and cap...
-
Asian Equities Sink on Covid FearsIt’s been a mixed start to the week for global equities benchmarks with US and European asset markets rema...